CYSTIC FIBROSIS LUNG
Clinical trials for CYSTIC FIBROSIS LUNG explained in plain language.
Never miss a new study
Get alerted when new CYSTIC FIBROSIS LUNG trials appear
Sign up with your email to follow new studies for CYSTIC FIBROSIS LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inhaled gene therapy aims to tackle cystic fibrosis from within
Disease control Recruiting nowThis early-stage trial tests a single inhaled dose of a gene therapy called 4D-710 in 30 adults with cystic fibrosis who cannot use current modulator drugs. The goal is to see if the treatment is safe and tolerable. Researchers will monitor side effects and changes in lung functi…
Matched conditions: CYSTIC FIBROSIS LUNG
Phase: PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 26, 2026 09:23 UTC
-
New inhaled therapy targets tough lung infections in cystic fibrosis
Disease control Recruiting nowThis study tests an inhaled drug called RSP-1502 in people with cystic fibrosis who have a chronic lung infection caused by Pseudomonas aeruginosa bacteria. The main goal is to see if the drug is safe and how the body handles it. About 72 participants aged 12 and older will recei…
Matched conditions: CYSTIC FIBROSIS LUNG
Phase: PHASE1, PHASE2 • Sponsor: Respirion Pharmaceuticals Pty Ltd • Aim: Disease control
Last updated May 26, 2026 09:20 UTC